Ondansetron Suppository: A Randomised, Double-Blind, Double-Dummy, Parallel-Group Comparison with Oral Ondansetron for the Prevention of Cyclophosphamide Induced Emesis and Nausea

Autor:	N.G.P. Davidson, L. Goedhals, J. McRae, S. Van Belle, W. Paska, B. McQuade
Rok vydání:	1997
Předmět:	Cancer Research medicine.drug_class business.industry Nausea General Medicine Suppository Ondansetron Oncology Tolerability Oral administration Anesthesia 5-HT3 antagonist Vomiting medicine Antiemetic medicine.symptom business medicine.drug
Zdroj:	Oncology. 54:380-386
ISSN:	1423-0232 0030-2414
DOI:	10.1159/000227723
Popis:	This multinational, multicentre, randomised, parallel-group study compared the safety, tolerability and efficacy of ondansetron 8 mg orally twice a day with ondansetron suppository 16 mg once daily in
Databáze:	OpenAIRE
Externí odkaz:	https://explore.openaire.eu/search/publication?articleId=doi_________::b2f2801021a8b7cbe54969e30fb1e0e5 https://doi.org/10.1159/000227723 Zobrazit plný text záznamu